Last Posted: Apr 26, 2020
- Mass screening weighed for type 1 diabetes risk
JC Frankel. Science April 23, 2020 - Coronavirus Antibody Tests: Can You Trust the Results? A team of scientists worked around the clock to evaluate 14 antibody tests. A few worked as advertised. Most did not.
A Mandavilli, NY Times, April 24, 2020 - ACE2 Homo-dimerization, Human Genomic variants and Interaction of Host Proteins Explain High Population Specific Differences in Outcomes of COVID19
S Sharma et al, BIORXIV, April 24, 2020 - Nearly All Patients Hospitalized With Covid-19 Had Chronic Health Issues, Study Finds- Only 6 percent of patients at one New York area health system had no chronic conditions. Hypertension, obesity and diabetes were common.
RC Rabin, NY Times, April 23, 2020 - A road map for the future: An exploration of attitudes, perceptions, and beliefs among African Americans to tailor health promotion of cancer-related genetic counseling and testing.
Lumpkins Crystal Y et al. Journal of genetic counseling 2020 Apr - Alpha-1 Antitrypsin Deficiency and Pregnancy.
Gaeckle Nate T et al. COPD 2020 Apr 1-7 - Integrated Transcriptome Analyses and Experimental Verifications of Mesenchymal-Associated TNFRSF1A as a Diagnostic and Prognostic Biomarker in Gliomas.
Yang Biao et al. Frontiers in oncology 2020 10250 - Protein disulphide isomerase can predict the clinical prognostic value and contribute to malignant progression in gliomas.
Hu Qing et al. Journal of cellular and molecular medicine 2020 Apr - The Challenge of Tracking COVID-19’s Stealthy Spread
NIH Director's Blog, April 23, 2020 - Tumor sequencing is useful to refine the analysis of germline variants in unexplained high-risk breast cancer families.
Van Marcke Cédric et al. Breast cancer research : BCR 2020 Apr 22(1) 36
.jpg)
No hay comentarios:
Publicar un comentario